Monika Głuch‐Lutwin

Novel multi-target-directed ligands for Alzheimer's disease: Combining cholinesterase inhibitors and 5-HT 6 receptor antagonists. Design, synthesis and biological evaluation

Anna Więckowska, Marcin Kołaczkowski, Adam Bucki et al. · European Journal of Medicinal Chemistry · 2016 · 84 citations · Full text

Molecular Pharmacology, Neurodegenerative Diseases, Drug Target +11

Novel Multitarget-Directed Ligands Aiming at Symptoms and Causes of Alzheimer’s Disease

Anna Więckowska, Tomasz Wichur, Justyna Godyń et al. · ACS Chemical Neuroscience · 2018 · 52 citations · Full text

Antidepressant- and Anxiolytic-Like Effects of New Dual 5-HT1A and 5-HT7 Antagonists in Animal Models

Karolina Pytka, Anna Partyka, Magdalena Jastrzębska‐Więsek et al. · PLoS ONE · 2015 · 50 citations · Full text

Psychotropic Medication, Psychopharmacology, Pharmacotherapy +24

New Dual Small Molecules for Alzheimer’s Disease Therapy Combining Histamine H₃ Receptor (H3R) Antagonism and Calcium Channels Blockade with Additional Cholinesterase Inhibition

R.S. Malek, Raquel L. Arribas, Alejandra Palomino‐Antolín et al. · Journal of Medicinal Chemistry · 2019 · 42 citations · Full text

A Comparison of the Anorectic Effect and Safety of the Alpha2-Adrenoceptor Ligands Guanfacine and Yohimbine in Rats with Diet-Induced Obesity

Magdalena Dudek, Joanna Knutelska, Marek Bednarski et al. · PLoS ONE · 2015 · 40 citations · Full text